Skip to main content

Security report for astrazeneca.pl

AstraZeneca · Healthcare · Poland

Medium risk. 5 critical or high findings in Email security, Security headers and 2 other checks.

Security score

69/100

Risk levelMedium

0–100, higher is better. How it is calculated

AstraZeneca Poland's website serves as a comprehensive corporate portal providing information about the company's pharmaceutical products, clinical trials, innovations, and sustainability initiatives targeted at Polish audiences including healthcare professionals and patients. The site reflects AstraZeneca's position as a leading global biopharmaceutical company with a strong focus on innovation and patient care. Technically, the website is built on Adobe Experience Manager CMS, hosted on AWS infrastructure, and employs modern analytics and tag management tools such as Adobe Analytics and Tealium. The site is mobile-optimized, accessible, and SEO-friendly, with a consistent and professional design. Security posture is strong with HTTPS enforced and cookie consent mechanisms in place, though explicit security headers and incident response disclosures could be improved. The absence of WHOIS data for the domain is notable but does not detract from the site's legitimacy given its corporate branding and linkage to official AstraZeneca domains. Overall, the website demonstrates a mature digital presence aligned with enterprise standards.

Scanned

NIS2 and GDPR posture

GDPR outside view
88/ 100 · Low
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

5 findings rated critical or high. Fix these first.

  1. Email security

    SPF, DKIM and DMARC stop others sending email that looks like it comes from your domain, a common route to phishing and invoice fraud.

    • Critical

      No email authentication configured

      Domain is vulnerable to email spoofing

      What to do: Implement SPF, DKIM, and DMARC immediately

  2. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing Content-Security-Policy header

      Controls resources the browser is allowed to load

      What to do: Implement a Content-Security-Policy appropriate for your application

      • ASVS V3.4.3
      • OWASP Secure Headers: OWASP Secure Headers Project recommends Content-Security-Policy: default-src 'self'; form-action 'self'; base-uri 'self'; object-src 'none';…

  3. SSL/TLS

    TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.

    • High

      Weak Protocols Supported

      Server supports weak protocols: TLSv1.1

      What to do: Disable TLS 1.0, TLS 1.1, and all SSL versions

      • CWE-327
      • OWASP A04:2025
      • ASVS V12.1.1

  4. DNS health

    DNS sends visitors and email to the right servers. Misconfigured records can cause outages or let someone redirect your traffic.

    • High

      Unregistered MX Record

      MX record points to unregistered domain: apsn05.zeneca.com

      What to do: Remove or fix MX record pointing to unregistered domain

      • RFC 5321 §5.1
      • NIS2 21(2)(i)
      • IR 2024/2690 12.4: Implementing Regulation (EU) 2024/2690, Annex point 12.4: Asset inventory
      • NIST CM-8: NIST SP 800-53 Rev. 5 CM-8: System Component Inventory
    • High

      Unregistered MX Record

      MX record points to unregistered domain: uw06.zeneca.com

      What to do: Remove or fix MX record pointing to unregistered domain

      • RFC 5321 §5.1
      • NIS2 21(2)(i)
      • IR 2024/2690 12.4: Implementing Regulation (EU) 2024/2690, Annex point 12.4: Asset inventory
      • NIST CM-8: NIST SP 800-53 Rev. 5 CM-8: System Component Inventory

Need hands-on remediation? Email guard@offseq.com

Keep watching astrazeneca.pl

This scan found 22 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. The full timeline opens with your unlock code.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
67
Security headers
55
Email security
60
DNS health
45
Network security
100
GDPR outside view
88
Average
69

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

AstraZeneca Poland operates as an essential entity within the healthcare sector, focusing on pharmaceutical research, development, and distribution. The website highlights key therapeutic areas such as oncology, cardiology, respiratory diseases, and vaccines. The business model centers on innovation and patient-centric solutions, supported by clinical trials and sustainability efforts. The company maintains a strong partnership ecosystem, linking to related AstraZeneca sites and MedImmune. The site’s content and certifications like TOP Employer 2023 reinforce its market credibility. Growth indicators include active news updates and educational initiatives. The absence of direct contact details on the homepage suggests a controlled communication channel, typical for large enterprises.

Security posture

The website exhibits a solid security posture with mandatory HTTPS encryption and a comprehensive cookie consent mechanism compliant with GDPR. Use of reputable third-party analytics and tag management platforms is evident, with no exposed sensitive data detected in the HTML content. However, explicit security headers such as X-Frame-Options and X-Content-Type-Options are not clearly present and should be verified. There is no public disclosure of security policies, incident response plans, or vulnerability disclosure programs, which are recommended for transparency and readiness. The site’s reliance on trusted cloud hosting (AWS) and modern CMS (Adobe Experience Manager) supports operational security. Overall, the security maturity is good but could benefit from enhanced policy visibility and header configurations.

Recommendations

  1. Verify and implement explicit security headers including X-Frame-Options and X-Content-Type-Options to enhance protection against clickjacking and MIME sniffing.
  2. Publish a clear security policy and incident response plan on the website to improve transparency and stakeholder trust.
  3. Establish and disclose a vulnerability disclosure or bug bounty program to encourage responsible reporting of security issues.
  4. Regularly audit third-party scripts and analytics tools to ensure they do not introduce vulnerabilities or privacy risks.
  5. Consider adding clear company contact information on the website to improve user trust and facilitate communication.
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
AstraZeneca
Description
AstraZeneca is an innovative biopharmaceutical company focused on developing and manufacturing modern medicines to combat major medical challenges. The Poland site provides information about the company's activities, products, clinical trials, innovations, and sustainability efforts.
Key services
Pharmaceutical products, Clinical trials, Research and innovation, Sustainability initiatives
Content quality
good
Branding
consistent

Technology

Stack
JavaScript, jQuery, Adobe Helix RUM, Tealium Tag Manager, CookieReports, Modernizr
Performance
moderate
Mobile
good
Accessibility
good
SEO
good

Security

Observed score
85/100
Good practices seen
  • HTTPS enforced
  • Cookie consent mechanism implemented
  • No exposed sensitive data in HTML
  • Use of modern analytics and tag management

Analytics and tracking

Services
Adobe Analytics, Tealium
Tracking level
extensive
Privacy practices
good

Advertising

Ad networks
Flashtalking
Tracking pixels
Adobe Analytics, Tealium, Flashtalking
Marketing tools
Tealium Tag Manager, Adobe Audience Manager
Transparency
good

Site quality

Design
good
User experience
good
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
high

Key observations

  1. Website is fully accessible with rich content and navigation.
  2. Strong corporate branding consistent with AstraZeneca global presence.
  3. Comprehensive cookie and privacy policies with consent mechanisms.
  4. Use of modern analytics and tag management tools.
  5. No contact emails or phone numbers explicitly found on homepage content.
  6. WHOIS data unavailable, which is unusual but not necessarily suspicious given the .pl registry note.
  7. No security policy or incident response information publicly disclosed.
  8. Social media links to official AstraZeneca Facebook, LinkedIn, and Twitter accounts.
  9. Website uses Adobe Experience Manager CMS and hosted on AWS infrastructure.
Technical notes

Notes

The website is built on Adobe Experience Manager, a robust enterprise CMS, and hosted on Amazon Web Services, ensuring scalability and reliability. It uses modern JavaScript libraries including jQuery and integrates advanced analytics and tag management via Adobe Analytics and Tealium. The site is mobile-optimized with responsive images and accessibility features. Performance is moderate, with asynchronous loading of scripts to improve user experience. SEO is supported by proper meta tags, canonical links, and structured data in JSON-LD format. The technical stack is mature and aligns with enterprise best practices, though continuous monitoring of third-party dependencies is advised to mitigate risks.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with astrazeneca.pl. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review astrazeneca.pl.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.